Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases

NCT05465863 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease 5D
Chronic Kidney Disease 5T

Interventions

BIOLOGICAL: SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®)

Sponsor

Istanbul University - Cerrahpasa